KRYS News and Press, Krystal Biotech Inc. From 05/08/24

PITTSBURGH, May 08, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the BofA Securities 2024 Health Care Conference on May 14, 2024, in Las Vegas. K...

2024-05-06 12:53:04 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Krystal Biotech (NASDAQ: KRYS ) just reported results for the first quarter of 2024. Krystal Biotech reported earnings per share of 46 cents. This was above the analyst es...

2024-05-06 11:44:08 ET Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Conference Call May 06, 2024 8:30 AM ET Company Participants Stéphane Paquette - VP, Business Development Krish Krishnan - Chairman and CEO Suma Krishnan - President of R&D Christin...

2024-05-06 08:03:12 ET More on Krystal Biotech Krystal Biotech's Future Brightens With Vyjuvek's Robust Launch Krystal Biotech: Ready For Launch Krystal Biotech confirms cancellation from Cowen conference due to CEO sickness Read the full article on Seeking...

Net product revenue of $45.3 million in 1Q and $95.9 million since August First patient dosed in inhaled KB707 study for locally advanced or metastatic tumors of the lung Received Fast Track Designations for both inhaled and intratumoral KB707 Strong balance shee...

PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....

2024-05-03 12:38:26 ET More on Krystal Biotech Krystal Biotech's Future Brightens With Vyjuvek's Robust Launch Krystal Biotech, Inc. (KRYS) Q4 2023 Earnings Call Transcript Krystal Biotech: Ready For Launch Krystal Biotech confirms cancellation from Cowen con...

2024-05-02 17:50:00 ET Summary Abeona Therapeutics is a gene therapy company with a lead product candidate, Pz-cel, for recessive epidermolysis bullosa, or RDEB. Pz-cel has shown higher efficacy than the competition in treating larger skin lesions in RDEB. Despite receiving a ...

PITTSBURGH, May 02, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting new preclinical data highlighting the potential of the Company’s HSV-1 base...

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $12.22 on volume of 208,602,591 shares CytomX Therapeutics Inc. (CTMX) rose 214.7% to $5.13 on volume of 203,288,355 shares Akanda Corp. (AKAN) rose 25.4% to $0.1166 on volume of 179,349,234 shares ...